CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Criteria for Iron Deficiency in Patients With Heart Failure 21st Century CE: The New Iron Age?

Original ResearchCirculation. 2018;139:489–501

JOURNAL:Circulation. Article Link

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery

Aragam KG, Chaffin M, GRADE Investigators. Keywords: nonischemic cardiomyopathy; genetic discovery, heart failure; CAD; atrial fibrillation

FULL TEXT PDF